Landesklinikum Wiener Neustadt

Wiener Neustadt 2700

4 studies enrolling now · 9 studies all time

What they study most

Cholangiocarcinoma, Colorectal Neoplasms, Gastric Cancer, Gastro-Oesophageal Cancer, Gastroesophageal Junction Cancer, ICD Replacement or Upgrade, Inappropriate Shocks From Implanted Defibrillator, Metabolic Dysfunction-Associated Steatotic Liver Disease, Pancreatic Cancer Metastatic, Pancreatic Cancer Stage IV, Pancreatic Ductal Adenocarcinoma, Refractory Metastatic Colorectal Cancer

Studies at this site

• Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer — Recruiting now
• A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes) — Recruiting now
• A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer — Recruiting now
• Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer — Recruiting now
• Study of Tinengotinib VS. Physician's Choice a Treatment of Subjects With FGFR-altered in Cholangiocarcinoma — Running, not enrolling
• RegoNivo vs Standard of Care Chemotherapy in AGOC — Completed
• Phase III Study of Trifluridine/Tipiracil With and Without Bevacizumab in Refractory Metastatic Colorectal Cancer Patients — Completed
• Basket Trial in Solid Tumors Harboring a Fusion of FGFR1, FGFR2 or FGFR3- (FUZE Clinical Trial) — Stopped early
• Observational Study on Inappropriate Therapies — Status unconfirmed